top of page


Cisterna uses proprietary technologies to build the next generation of mRNA.


Cisterna is dedicated to advancing the field of mRNA-based therapeutics by providing exceptionally high-quality mRNA. Our broader mission is to tackle the multifaceted challenges inherent in production of mRNA for R&D. These include quality, quantity, cost and delivery lead time. As mRNA technology continues to evolve, we are committed to providing rapid, innovative and effective solutions to unlock the boundless potential of mRNA as a therapeutic modality. 


Cisterna employs cutting-edge chemistry and leverages the power of ribozymes to create mRNA molecules. At the heart of our innovation lies the proprietary process known as SPecific Capture and Cleavage (SPECC), an advanced platform for producing mRNA of unparalleled purity.

Pilot Program now open

More information available soon

Backed by

YC Logo Expanded — White.png

Copyright © 2024 Cisterna Biologics 

bottom of page